Form 4: Amedisys Director Coye Receives Stock Award
SEC Form 4 Filing
Director Molly Joel Coye receives 1,690 restricted stock units from Amedisys Inc. vesting on May 3, 2026.
Summary
- Molly Joel Coye, a director of Amedisys Inc., received 1,690 time-based Restricted Stock Units (RSUs) on May 3, 2025.
- Each RSU represents a contingent right to receive one share of Amedisys' common stock.
- The RSUs will vest 100% on May 3, 2026, contingent upon Coye's continued service as a non-employee member of the Issuer's Board of Directors.
Sentiment
Score: 7
Explanation: The sentiment is neutral to positive as it reflects standard compensation practices for board members, aligning their interests with shareholders.
Positives
- The stock award aligns the director's interests with those of the shareholders, incentivizing continued service and contribution to the company's success.
Future Outlook
The director's continued service is predicated on the vesting of the stock award.
Industry Context
Stock awards are a common form of compensation for board members, aligning their interests with the long-term performance of the company.
Stakeholder Impact
- Shareholders may view the stock award positively as it incentivizes the director to contribute to the company's long-term success.
Key Dates
| Date | Description |
|---|---|
| 05/03/2025 | Date of transaction: Molly Joel Coye received 1,690 Restricted Stock Units. |
| 05/03/2026 | Vesting date: 100% of the Restricted Stock Units will vest, contingent upon continued service. |
| 05/06/2025 | Date of signature: Jennifer Guckert Griffin signed the document pursuant to a power of attorney. |
Keywords
Amedisys, Director, Stock Award, Restricted Stock Units, RSU, Beneficial Ownership, Form 4, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.